EP About this file: EP0273202

EP0273202 - Use of hydroxycarboxylic acids to enhance therapeutic effects of topical compositions for fungal infections and pigmented spots. [Right-click to bookmark this link]
Former [1988/27]	Additives enhancing topical actions of therapeutic agents
	[1995/25]
Status	Patent revoked Status updated on 16.03.2007 Database last updated on 05.04.2025
Most recent event Tooltip	20.07.2007	Lapse of the patent in a contracting state New state(s): IT	published on 22.08.2007 [2007/34]
Applicant(s)	For all designated states Van Scott, Eugene J., Dr. 3 Hidden Land Abington Pennsylvania 19001 / US
	For all designated states Yu, Ruey J., Dr. 4 Lindenwold Avenue Ambler Pennsylvania 19002 / US
	[N/P]
Former [1988/27]	For all designated states Van Scott, Eugene J., Dr. 3 Hidden Land Abington Pennsylvania 19001 / US
	For all designated states Yu, Ruey J., Dr. 4 Lindenwold Avenue Ambler Pennsylvania 19002 / US
Inventor(s)	01 / see applicant ...
	[1988/27]
Representative(s)	Goldbach, Klara, et al Grünecker Kinkeldey Stockmair & Schwanhäusser Anwaltssozietät Leopoldstrasse 4 80802 München / DE
	[N/P]
Former [2001/32]	Goldbach, Klara, Dr., et al Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät Maximilianstrasse 58 80538 München / DE
Former [1996/31]	Olgemöller, Luitgard, Dr., et al Leonhard - Olgemöller - Fricke, Patentanwälte, Josephspitalstrasse 7 80331 München / DE
Former [1988/27]	Henkel, Feiler, Hänzel & Partner Möhlstrasse 37 D-81675 München / DE
Application number, filing date	87117405.8	25.11.1987
	[1988/27]
Priority number, date	US19860945680	23.12.1986 Original published format: US 945680
	[1988/27]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	EP0273202
	Date:	06.07.1988
	Language:	EN
	[1988/27]
	Type:	A3 Search report
	No.:	EP0273202
	Date:	06.06.1990
	Language:	EN
	[1990/23]
	Type:	B1 Patent specification
	No.:	EP0273202
	Date:	21.06.1995
	Language:	EN
	[1995/25]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	19.04.1990
Classification	IPC:	A61K47/12, A61K31/4174, A61K31/7048, A61K47/14	[2006/15]
	CPC:	A61Q17/005 (EP,US); A61K31/19 (EP,US); A61K31/191 (EP,US); A61K31/192 (EP,US); A61K31/194 (EP,US); A61K31/195 (EP,US); (+) A61K31/20 (EP,US); A61K31/202 (EP,US); A61K31/365 (EP,US); A61K31/366 (EP,US); A61K31/40 (EP,US); A61K31/405 (EP,US); A61K31/415 (EP,US); A61K31/445 (EP,US); A61K31/66 (EP,US); A61K31/70 (EP,US); A61K31/7048 (EP,US); A61K31/715 (EP,US); A61K45/06 (EP,US); A61K47/12 (EP,US); A61K47/183 (EP,US); A61K47/24 (EP,US); A61K47/26 (EP,US); A61K8/347 (EP,US); A61K8/362 (EP,US); A61K8/365 (EP,US); A61K8/37 (EP,US); A61K8/375 (EP,US); A61K8/38 (EP,US); A61K8/42 (EP,US); A61K8/43 (EP,US); A61K8/494 (EP,US); A61K8/4953 (EP,US); A61K8/4973 (EP,US); A61K8/60 (EP,US); A61K8/63 (EP,US); A61K8/671 (EP,US); A61K8/675 (EP,US); A61K8/676 (EP,US); A61K9/0014 (EP,US); A61Q17/04 (EP,US); A61Q19/00 (EP,US); A61Q19/007 (EP,US); A61Q19/008 (EP,US); A61Q19/02 (EP,US); A61Q19/08 (EP,US); A61Q19/10 (EP,US); A61Q5/006 (EP,US); A61Q5/02 (EP,US); A61Q7/00 (EP,US); A61Q17/00 (EP,US) (-)
	C-Set:	A61K31/195, A61K2300/00 (US,EP); A61K31/19, A61K2300/00 (US,EP); A61K31/405, A61K2300/00 (US,EP); A61K31/40, A61K2300/00 (US,EP); (+) A61K31/415, A61K2300/00 (EP,US); A61K31/445, A61K2300/00 (EP,US); A61K31/66, A61K2300/00 (EP,US); A61K31/70, A61K2300/00 (EP,US); A61K31/715, A61K2300/00 (EP,US) (-)
	Former IPC [1988/27]	A61K47/00
Designated contracting states	DE, ES, FR, GB, IT [1988/27]
Title	German:	Verwendung von Hydroxycarbonsäuren zur Verstärkung der therapeutischen Effekte von topischen Zubereitungen gegen Pilzinfektionen und Pigmentflecken	[1995/25]
	English:	Use of hydroxycarboxylic acids to enhance therapeutic effects of topical compositions for fungal infections and pigmented spots.	[1995/25]
	French:	Utilisation d'acides polycarboxyliques améliorant l'activité thérapeutique de compositions topiques contre les infections mycotiques et les taches pigmentées.	[1995/25]
	Former [1988/27]	Additiv zur Verbesserung der Topischen Aktivitäten von therapeutischen Mitteln
	Former [1988/27]	Additives enhancing topical actions of therapeutic agents
	Former [1988/27]	Additifs améliorant l'activité topique d'agents thérapeutiques
Miscellaneous	EPB 1995/25: Teilanmeldung 94102151.1 eingereicht am 25/11/87
	EPB 1995/25: Divisional application 94102151.1 filed on 25/11/87
	EPB 1995/25: Demande divisionnaire 94102151.1 déposée le 25/11/87
Examination procedure	07.09.1990	Examination requested [1990/44]
	13.08.1991	Despatch of a communication from the examining division (Time limit: M06)
	07.02.1992	Reply to a communication from the examining division
	28.07.1992	Despatch of a communication from the examining division (Time limit: M06)
	04.02.1993	Reply to a communication from the examining division
	14.12.1993	Date of oral proceedings
	07.01.1994	Despatch of a communication from the examining division (Time limit: M02)
	07.01.1994	Minutes of oral proceedings despatched
	17.03.1994	Reply to a communication from the examining division
	03.05.1994	Despatch of communication of intention to grant (Approval: No)
	07.11.1994	Despatch of communication of intention to grant (Approval: later approval)
	09.12.1994	Communication of intention to grant the patent
	09.03.1995	Fee for grant paid
	09.03.1995	Fee for publishing/printing paid
	09.04.1997	Observations by third parties
Divisional application(s)	EP94102151.1 / EP0599819
	EP97100470.0 / EP0770399
Opposition(s)	Opponent(s)	01 20.03.1996 27.03.1996 ADMISSIBLE The Procter & Gamble Company One Procter & Gamble Plaza Cincinnati, OHIO 45202 / US Opponent's representative Kyle, Diana Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB
		02 21.03.1996 01.04.1996 ADMISSIBLE UNILEVER PLC / UNILEVER NV Unilever House, Blackfriars/Weena 455 London EC4P 4BQ/3013 AL Rotterdam / GB Opponent's representative Mulder, Cornelis Willem Reinier, et al, et al Unilever Patent Group Colworth House Sharnbrook Bedford MK44 1LQ / GB
		[N/P]
	Former [2005/40]
	Opponent(s)	01 20.03.1996 27.03.1996 ADMISSIBLE The Procter & Gamble Company One Procter & Gamble Plaza Cincinnati, OHIO 45202 / US Opponent's representative Kyle, Diana Elkington and Fife LLP, Prospect House 8 Pembroke Road Sevenoaks Kent TN13 1XR / GB
		02 21.03.1996 01.04.1996 ADMISSIBLE Unilever PLC/ Unilever NV Unilever House, Blackfriars/ Weena 455 GB London EC4P 4BQ/ NL 3013 A1 Rotterdam / GB Opponent's representative Mulder, Cornelis Willem Reinier, Dr., et al, et al Unilever PLC, Patent Division, Colworth House Sharnbrook, Bedford MK44 1LQ / GB
	Former [2003/39]
	Opponent(s)	01 20.03.1996 27.03.1996 ADMISSIBLE The Procter & Gamble Company One Procter & Gamble Plaza Cincinnati, OHIO 45202 / US Opponent's representative Wilding, Richard Alan Procter & Gamble Technical Centers Ltd. Rusham Park Whitehall Lane Egham, Surrey TW20 9NW / GB
		02 21.03.1996 01.04.1996 ADMISSIBLE Unilever PLC/ Unilever NV Unilever House, Blackfriars/ Weena 455 GB London EC4P 4BQ/ NL 3013 A1 Rotterdam / GB Opponent's representative Mulder, Cornelis Willem Reinier, Dr., et al, et al Unilever PLC, Patent Division, Colworth House Sharnbrook, Bedford MK44 1LQ / GB
	Former [2001/44]
	Opponent(s)	01 20.03.1996 27.03.1996 ADMISSIBLE The Procter & Gamble Company One Procter & Gamble Plaza Cincinnati, OHIO 45202 / US Opponent's representative Wilding, Richard Alan Procter & Gamble Technical Centers Ltd. Rusham Park Whitehall Lane Egham, Surrey TW20 9NW / GB
		02 21.03.1996 01.04.1996 ADMISSIBLE Unilever PLC/ Unilever NV Unilever House, Blackfriars/ Weena 455 GB London EC4P 4BQ/ NL 3013 A1 Rotterdam / GB Opponent's representative Evans, Jacqueline Gail Victoria Unilever plc Patent Division Colworth House Sharnbrook Bedford MK44 1LQ / GB
	Former [1996/21]
	Opponent(s)	01 20.03.1996 27.03.1996 ADMISSIBLE The Procter & Gamble Company One Procter & Gamble Plaza Cincinnati, OHIO 45202 / US Opponent's representative Kyle, Diana Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB
		02 21.03.1996 01.04.1996 ADMISSIBLE Unilever PLC/ Unilever NV Unilever House, Blackfriars/ Weena 455 GB London EC4P 4BQ/ NL 3013 A1 Rotterdam / GB Opponent's representative Evans, Jacqueline Gail Victoria Unilever plc Patent Division Colworth House Sharnbrook Bedford MK44 1LQ / GB
	Former [1996/20]
	Opponent(s)	01 20.03.1996 27.03.1996 ADMISSIBLE The Procter & Gamble Company One Procter & Gamble Plaza Cincinnati, OHIO 45202 / US Opponent's representative Kyle, Diana Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB
		02 21.03.1996 Unilever PLC Unilever House Blackfriars London EC44BQ / GB Opponent's representative Evans, Jacqueline Gail Victoria Unilever plc Patent Division Colworth House Sharnbrook Bedford MK44 1LQ / GB
	Former [1996/19]
	Opponent(s)	01 20.03.1996 ADMISSIBLE The Procter & Gamble Company One Procter & Gamble Plaza Cincinnati, OHIO 45202 / US Opponent's representative Kyle, Diana Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB
	02.05.1996	Invitation to proprietor to file observations on the notice of opposition
	12.11.1996	Reply of patent proprietor to notice(s) of opposition
	09.12.1996	Despatch of a communication from the opposition division (Time limit: M04)
	09.12.1996	Despatch of a communication from the opposition division (Time limit: M09)
	01.04.1997	Reply to a communication from the opposition division
	18.09.1997	Reply to a communication from the opposition division
	18.11.1998	Despatch of a communication from the opposition division (Time limit: M08)
	27.07.1999	Reply to a communication from the opposition division
	31.01.2001	Date of oral proceedings
	19.02.2001	Despatch of interlocutory decision in opposition
	19.02.2001	Despatch of minutes of oral proceedings
	29.11.2005	Legal effect of interlocutory decision in opposition
	27.02.2006	Despatch of communication that the patent will be maintained as amended
	27.10.2006	Despatch of communication that the patent will be revoked
	06.11.2006	Legal effect of revocation of patent [2007/16]
Appeal following opposition	30.04.2001	Appeal received No. T0580/01
	02.07.2001	Statement of grounds filed
	29.11.2005	Result of appeal procedure: appeal of the proprietor was rejected
	29.11.2005	Date of oral proceedings
	06.12.2005	Minutes of the oral proceedings despatched
Fees paid	Renewal fee
	18.10.1989	Renewal fee patent year 03
	22.10.1990	Renewal fee patent year 04
	21.10.1991	Renewal fee patent year 05
	12.10.1992	Renewal fee patent year 06
	01.10.1993	Renewal fee patent year 07
	07.11.1994	Renewal fee patent year 08
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	GB	25.11.2005
	IT	25.11.2005
	ES	26.11.2005
	DE	01.06.2006
	FR	31.07.2006
	[2007/34]
Former [2007/30]	GB	25.11.2005
	ES	26.11.2005
	DE	01.06.2006
	FR	31.07.2006
Former [2007/21]	GB	25.11.2005
	ES	26.11.2005
	DE	01.06.2006
Former [2007/16]	GB	25.11.2005
	DE	01.06.2006
Former [2007/01]	DE	01.06.2006
Documents cited:	Search	[X]RO79428 ;
		[X]FR2456522 (KAO CORP [JP]);
		[A]US4287214 (VAN SCOTT EUGENE J, et al);
		[X]EP0042290 (JANSSEN PHARMACEUTICA NV [BE]);
		[X]DE3200766 (TOYO JOZO KK [JP]);
		[X]EP0067513 (TAKEDA CHEMICAL INDUSTRIES LTD [JP]);
		[X]US4406896 (HIGUCHI TAKERU [US], et al);
		[X]EP0126348 (KYOTO PHARMA IND [JP]);
		[X]EP0152281 (YAMANOUCHI PHARMA CO LTD [JP]);
		[X]EP0183527 (YAMANOUCHI PHARMA CO LTD [JP]);
		[A]EP0187433 (TEIJIN LTD [JP]);
		[XP]EP0225005 (NITTO ELECTRIC IND CO [JP]);
		[XP]EP0242967 (UNILEVER PLC [GB], et al)
		[X] - CHEMICAL ABSTRACTS. vol. 103, no. 2, 15 July 1985, abstract no. 11494k, Columbus, Ohio, USA; & RO-A-79 428 (28-02-1983), & RO79428 A 00000000

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.32; 34p